Kazakh Scientist Unveils Low-Cost Anticancer Drug DVC
A Kazakh scientist has developed an affordable anticancer drug called DVC. The treatment, made from low-cost ingredients, disrupts the nutritional supply to cancer cells. After years of research, the drug is now moving closer to clinical use.
Dos Sarbassov, the scientist behind DVC, spent 13 years at the MD Anderson Cancer Center in Texas before returning to Kazakhstan. His work led to a drug composed of deoxy acid, glucose, and arsenic, costing only 8,000 to 10,000 tenge per dose.
DVC’s development marks a step toward accessible cancer care. The drug’s affordability and early trial results have drawn attention, though regulatory hurdles remain. The next phase of testing will determine its future availability for patients.
Read also:
- Executive from significant German automobile corporation advocates for a truthful assessment of transition toward electric vehicles
- United Kingdom Christians Voice Opposition to Assisted Dying Legislation
- Democrats are subtly dismantling the Affordable Care Act. Here's the breakdown
- Financial Aid Initiatives for Ukraine Through ERA Loans
